Skip to Content
Symphonies
Top Patent Approvals 2010-2017
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

Buys an equal-weight basket of companies that led in patent approvals during 2010–2017—an easy-to-understand bet on innovation intensity. Tech- and semiconductor-heavy with some industrial, consumer, and healthcare names; includes several foreign ADRs.
NutHow it works
Each quarter, buy equal amounts of ~25 companies that ranked highest for patents granted in 2010–2017 (using yearly percentiles to smooth rule changes). Tilt: chipmakers and big tech (AAPL, MSFT, IBM, INTC, TSM—tickers are stock symbols), plus industrials (GE, BA), consumer (NKE, PG), healthcare (MDT), energy (BKR), and several foreign ADRs (SONY, SAP, HMC).
CheckmarkValue prop
Out-of-sample edge: 15.65% annualized return with ~0.79 Sharpe and positive alpha from a patent-led, equal-weight basket. Quarterly rebalance seeks durable upside vs the S&P, with strong risk-adjusted metrics, though ~29% drawdowns.

Loading backtest data...

Invest in this strategy
OOS Start Date
Feb 13, 2022
Trading Setting
Quarterly
Type
Stocks
Category
Equities, innovation/patents, equal-weight, quarterly rebalance, tech-heavy, global adrs
Tickers in this symphonyThis symphony trades 24 assets in total
Ticker
Type
AAPL
Apple Inc.
Stocks
AMAT
Applied Materials Inc
Stocks
AVGO
Broadcom Inc. Common Stock
Stocks
BA
Boeing Company
Stocks
BKR
Baker Hughes Company
Stocks
GE
GE Aerospace
Stocks
HMC
Honda Motor Co., Ltd. American Depositary Share, each representing three (3) shares of Common Stock
Stocks
HON
Honeywell International, Inc.
Stocks
IBM
International Business Machines Corporation
Stocks
INTC
Intel Corp
Stocks

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"Top Patent Approvals 2010-2017" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"Top Patent Approvals 2010-2017" is currently allocated toLPL, MU, AMAT, AVGO, INTC, QCOM, TXN, GE, HON, SAP, LPLA, HMC, BA, AAPL, ORCL, SONY, XRX, TSM, MDT, PG, MSFT, NKE, IBMandBKR. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "Top Patent Approvals 2010-2017" has returned 13.25%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "Top Patent Approvals 2010-2017" is 29.46%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "Top Patent Approvals 2010-2017", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, and options.